| http://purl.uniprot.org/citations/37686333 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/37686333 | http://www.w3.org/2000/01/rdf-schema#comment | "Specialized pro-resolving mediators (SPMs) and especially Resolvin E1 (RvE1) can actively terminate inflammation and promote healing during lung diseases such as acute respiratory distress syndrome (ARDS). Although ARDS primarily affects the lung, many ARDS patients also develop neurocognitive impairments. To investigate the connection between the lung and brain during ARDS and the therapeutic potential of SPMs and its derivatives, fat-1 mice were crossbred with RvE1 receptor knockout mice. ARDS was induced in these mice by intratracheal application of lipopolysaccharide (LPS, 10 µg). Mice were sacrificed at 0 h, 4 h, 24 h, 72 h, and 120 h post inflammation, and effects on the lung, liver, and brain were assessed by RT-PCR, multiplex, immunohistochemistry, Western blot, and LC-MS/MS. Protein and mRNA analyses of the lung, liver, and hypothalamus revealed LPS-induced lung inflammation increased inflammatory signaling in the hypothalamus despite low signaling in the periphery. Neutrophil recruitment in different brain structures was determined by immunohistochemical staining. Overall, we showed that immune cell trafficking to the brain contributed to immune-to-brain communication during ARDS rather than cytokines. Deficiency in RvE1 receptors and enhanced omega-3 polyunsaturated fatty acid levels (fat-1 mice) affect lung-brain interaction during ARDS by altering profiles of several inflammatory and lipid mediators and glial activity markers."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.org/dc/terms/identifier | "doi:10.3390/ijms241713524"xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Kitagawa H."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Hernandez J."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Korber S."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Sommer N."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Hecker M."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Mayer K."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Reiche S."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Culmsee C."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Herden C."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Kang J.X."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Michels S."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Rummel C."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Schaffer J."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Bier J."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Welter J."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/author | "Pflieger F.J."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/date | "2023"xsd:gYear |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/name | "Int J Mol Sci"xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/pages | "13524"xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/title | "n-3 Polyunsaturated Fatty Acids Modulate LPS-Induced ARDS and the Lung-Brain Axis of Communication in Wild-Type versus Fat-1 Mice Genetically Modified for Leukotriene B4 Receptor 1 or Chemerin Receptor 23 Knockout."xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://purl.uniprot.org/core/volume | "24"xsd:string |
| http://purl.uniprot.org/citations/37686333 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/37686333 |